Menu
Not yet recruiting NCT07002840

Effect of Cross-legged Sitting Among Patients With Unilateral Hip Developmental Dysplasia

No phase Interventional Hip Developmental Dysplasia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Cross- legged sitting position, Physical Therapy Rehabilitation Program.
Who it may be relevant to
Registry conditions: Hip Developmental Dysplasia. Basic parameters: 9 months — 10 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of Engaging the Cross-legged Sitting in Rehabilitation Among Patients With Unilateral Hip Developmental Dysplasia According to Gait Parameters, Foot Pressure and Muscular Electrical Activity.

Overview

One of the most common infant developmental diseases is Hip dysplasia which is mostly seen among female' babies and leads to hip instability due to partial or full hip dislocation \[1\]. Physical therapy's role plays a significant role in treating hip dysplasia by creating new walking habits as an adaptation way and compensation for the deformity \[3\]. Focusing on the muscles that produce hip abduction force is a basic item of the hip dysplasia rehabilitation program \[4\]. Cross-legged sitting position can be considered as a common and easy position that might enhance the range of motion of the lower limb joints \[5\]. While unilateral hip developmental dysplasia has been widely distributed among newborns, especially in the last few years, the role of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation programs on improving the temporospatial parameters, muscular electrical activity and foot pressure distributing is still not clear. Therefore, this study aimed to analyze the effects of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation program among patients with UHDD by comparing the group who participated in rehabilitation program with CLS to the other without. To understand the importance of including Cross-legged sitting technique in physical therapy and rehabilitation program of Unilateral Hip Developmental Dysplasia (UHDD) to enhance the spatial and temporal measures, achieving a healthy distribution of foot pressure, increasing the electrical activity of lower limb muscles and improving the overall gait pattern. No risks at all. All instruments and techniques in this study are safe and used regularly without any hazards. The data will be stored and archived on a password-protected computer for safety and security purposes. After accomplishing the research and getting the outcomes, the results of the research may be published as an academic article in a peer-reviewed journal. In another word, no personal data will be published at all. Taking part in the study and withdrawing at any time is completely voluntary with no need to give any reason.

Interventions

  • Other Cross- legged sitting position
    CLS in which the legs were crossed with hip and knee joints flexed
  • Other Physical Therapy Rehabilitation Program
    Strengthening Exercises Stretching Exercises Range of Motion Exercises

Primary outcome measures

  • Gait Temporospatial Parameters [Time frame: 3 months]
  • Muscle Electrical Activity [Time frame: 3 months]
Secondary outcome measures (1)
  • Foot Pressure [Time frame: 3 months]

Eligibility criteria

Inclusion criteria

  • age group from 9 months to 10 years old
  • all participants suffer from Unilateral Hip Developmental Dysplasia (UHDD)
  • participants should be healthy in general

Exclusion criteria

Any participant with a history of neurological disorders, lower extremities previous surgical intervention, lower limb deformities, flat feet or high body mass index will be excluded from this study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07002840 · HAPO-13-S-(001)-(7371)

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗